Horizon Therapeutics Public Limited Company
NASDAQ: HZNP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Timothy P. Walbert
- Employees
- 2,190
- Headquarters
- Dublin, Ireland
- IPO year
- 2011
- Market cap
- $26.6B
- Website
- https://www.horizontherapeutics.com
Loading HZNP…
Loading profile data…Frequently asked questions about HZNP
What does Horizon Therapeutics Public Limited Company (HZNP) do?
Horizon Therapeutics Public Limited Company operates as a biotechnology enterprise, primarily concentrating on the identification, refinement, and commercialization of pharmaceutical products designed to address significant medical needs for individuals afflicted by rare, autoimmune, and severe inflammatory conditions. The company's operations a...
Where does HZNP trade?
Horizon Therapeutics Public Limited Company (HZNP) trades on the NASDAQ Global Select.
What sector is HZNP in?
Horizon Therapeutics Public Limited Company (HZNP) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Horizon Therapeutics Public Limited Company?
Timothy P. Walbert is the chief executive officer of Horizon Therapeutics Public Limited Company (HZNP).
Where is Horizon Therapeutics Public Limited Company headquartered?
Horizon Therapeutics Public Limited Company is headquartered in Ireland.
Does HZNP pay a dividend?
Horizon Therapeutics Public Limited Company (HZNP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HZNP go public?
Horizon Therapeutics Public Limited Company (HZNP) completed its initial public offering in 2011.